What about us? Recent advances in the treatment of chronic hepatitis C threaten to leave some parts of the world behind

被引:3
作者
Ahmed, F. [1 ]
机构
[1] Aga Khan Univ, Div Gastroenterol, Karachi 75350, Pakistan
关键词
boceprevir; hepatitis C; Pakistan; Telaprevir; INFECTION;
D O I
10.1111/j.1365-2893.2012.01613.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
. Directly acting antiviral (DAA) agents are currently revolutionizing the treatment of chronic hepatitis C infection. The first generation of these agents have significant limitations including cost issues that are of particular concern in the developing world and a lack of efficacy in genotype 3 patients. Both of these concerns are of particular relevance in Pakistan.
引用
收藏
页码:367 / 368
页数:2
相关论文
共 8 条
[1]   Global hepatitis, migration and its impact on Western healthcare [J].
Ahmed, Furqaan ;
Foster, Graham R. .
GUT, 2010, 59 (08) :1009-1011
[2]   Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C [J].
Bochud, Pierre-Yves ;
Cai, Tao ;
Overbeck, Kathrin ;
Bochud, Murielle ;
Dufours, Jean-Francois ;
Muellhaupt, Beat ;
Borovicka, Jan ;
Heim, Markus ;
Moradpour, Darius ;
Cerny, Andreas ;
Malinverni, Raffaele ;
Francioli, Patrick ;
Negro, Francesco .
JOURNAL OF HEPATOLOGY, 2009, 51 (04) :655-666
[3]   Telaprevir Alone or With Peginterferon and Ribavirin Reduces HCV RNA in Patients With Chronic Genotype 2 but Not Genotype 3 Infections [J].
Foster, Graham R. ;
Hezode, Christophe ;
Bronowicki, Jean-Pierre ;
Carosi, Giampiero ;
Weiland, Ola ;
Verlinden, Lieselotte ;
van Heeswijk, Rolf ;
van Baelen, Ben ;
Picchio, Gaston ;
Beumont, Maria .
GASTROENTEROLOGY, 2011, 141 (03) :881-U604
[4]   Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial [J].
Gane, Edward J. ;
Roberts, Stuart K. ;
Stedman, Catherine A. M. ;
Angus, Peter W. ;
Ritchie, Brett ;
Elston, Rob ;
Ipe, David ;
Morcos, Peter N. ;
Baher, Linda ;
Najera, Isabel ;
Chu, Tom ;
Lopatin, Uri ;
Berrey, M. Michelle ;
Bradford, William ;
Laughlin, Mark ;
Shulman, Nancy S. ;
Smith, Patrick F. .
LANCET, 2010, 376 (9751) :1467-1475
[5]  
Jafri Wasim, 2008, Trop Gastroenterol, V29, P194
[6]  
Mohsin M, 2011, PAK J GASROENTEROL, V25, P5
[7]   Incidence and risk factors for community-acquired hepatitis C infection from birth to 5 years of age in rural Egyptian children [J].
Saleh, Doa'a A. ;
Shebl, Fatma M. ;
El-Kamary, Samer S. ;
Magder, Laurence S. ;
Allam, Alif ;
Abdel-Hamid, Mohamed ;
Mikhail, Nabiel ;
Hashem, Mohamed ;
Sharaf, Soraya ;
Stoszek, Sonia K. ;
Strickland, G. Thomas .
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 2010, 104 (05) :357-363
[8]   New Therapies for Hepatitis C Virus Infection [J].
Soriano, Vincent ;
Peters, Marion G. ;
Zeuzem, Stefan .
CLINICAL INFECTIOUS DISEASES, 2009, 48 (03) :313-320